In this article produced for Practice Nurse, author, PCRS Chair, Carol Stonham, describes FeNO testing and its role in diagnosing respiratory disease. She discusses the advantages and limitations of this test.
PCRS have issued a position statement on strategies to care for patients with respiratory disease and frailty in the community setting. Frailty is thought to affect around 10% of those aged over 65 years and up to half of those aged over 85 years. The health and social care needs of these vulnerable patients can be complex and require a holistic approach that should involve confirmation of current diagnoses and review of all medications giving consideration to the goals of treatment, likely benefits and likely side effects.
Noel Baxter PCRS Policy Lead and Tracey Lonergan PCRS Policy Coordinator.
Presented by Darush Attar-Zadeh and Katherine Hickman, this session challenged delegates on their prescribing habits and attention to patient behaviours, and provided tangible tools and techniques for immediate adoption into practice to improve asthma outcomes.
Date for review: 12th June 2025
The captain of your asthma care should be your regular preventer inhaler, not the co-pilot blue inhaler.
Succinct guidance on the key elements of a good respiratory review for people with asthma
You may also be interested in...
ARC is a global social movement created by the International Primary Care Respiratory Group (IPCRG) to drive change and disrupt the status quo in asthma management.
The mMRC (Modified Medical Research Council) Dyspnoea Scale is used to assess the degree of baseline functional disability due to dyspnoea.
The PCRS Greener Respiratory Healthcare Quality Improvement (QI) toolkit has been developed to support HCPs working in the primary care setting to understand and evaluate the environmental impact of their clinical practice, identify ways to reduce this impact, set goals and priorities and evaluat
Self-reported during community pharmacy consultations in London